Behavioral variant of frontotemporal dementia

Behavioral variant frontotemporal dementia (bvFTD) is the most common clinical subtype of frontotemporal dementia (FTD), a group of neurodegenerative disorders primarily affecting the frontal and temporal lobes of the brain. Also known as frontal variant FTD or Pick's disease (historically), bvFTD is characterized by progressive deterioration of personality, social conduct, and behavior, often with relative preservation of memory in the early stages. The disease predominantly affects the prefrontal cortical regions responsible for executive function, emotional regulation, and social cognition. Key clinical features include early and progressive changes in personality and behavior, such as social disinhibition (socially inappropriate actions, loss of manners), apathy or inertia, loss of empathy or sympathy for others, perseverative or compulsive behaviors, hyperorality and dietary changes (such as binge eating or preference for sweets), and executive dysfunction. Patients often lack insight into their behavioral changes, which can be particularly distressing for families and caregivers. Psychiatric misdiagnosis is common early in the disease course. Approximately 30-50% of bvFTD cases have a family history of dementia, psychiatric disease, or motor neuron disease, and about 10-20% follow an autosomal dominant inheritance pattern linked to mutations in genes such as MAPT (microtubule-associated protein tau), GRN (progranulin), and C9orf72 (chromosome 9 open reading frame 72). Sporadic cases without identifiable genetic cause also occur frequently. Typical onset is between 45 and 65 years of age, though earlier and later presentations are possible. There is currently no disease-modifying treatment for bvFTD. Management is symptomatic and supportive, involving behavioral interventions, selective serotonin reuptake inhibitors (SSRIs) for behavioral symptoms, caregiver education, and multidisciplinary care including speech therapy, occupational therapy, and neuropsychological support. The disease is progressive, with a median survival of approximately 6-9 years from symptom onset.

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Common questions about Behavioral variant of frontotemporal dementia